NUTRACEUTICAL INTERNATIONAL CORP
Healthcare · Medicinal Chemicals & Botanical Products · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | |
|---|---|---|---|---|---|---|
| Revenue | $233.0M | $216.5M | $214.5M | $208.4M | $200.4M | $188.1M |
| Operating income | $29.2M | $24.3M | $26.5M | $28.1M | $25.7M | $25.3M |
| Net income | — | — | — | — | — | — |
| Total assets | $235.9M | $212.4M | $214.8M | $192.3M | $185.9M | $171.7M |
| Total liabilities | $63.9M | $52.2M | $65.2M | $54.4M | $54.9M | $52.0M |
| Equity | $172.0M | $160.2M | $149.6M | $137.9M | $131.1M | $119.7M |
| EPS (diluted) | $2.00 | $1.59 | $1.62 | $1.73 | $1.59 | $1.51 |
| Shares out. | 9.2M | 9.5M | 9.6M | 9.8M | 9.8M | 10.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2016- Operating margin
- 12.5%
- Net margin
- —
- Return on equity
- —
- Return on assets
- —
- Return on capital (ROCE)
- 13.5%
- Liabilities / assets
- 27.1%
- Debt / equity
- 0.37×
- Book value / share
- $18.69
- Revenue growth (YoY)
- 7.6%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2016- Altman Z″ (distress)
- 8.09safe
- Piotroski F-Score
- 4/6mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 5 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Dec 15, 2011
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · New financial obligation · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsAug 25, 2017
- Shareholder voteAug 21, 2017
- Results of operationsJul 27, 2017
- Other material eventJul 20, 2017
- Other material eventJun 9, 2017
- Director / officer changeMay 23, 2017
- Entered a material agreement · Other material eventMay 22, 2017
- Results of operationsApr 27, 2017
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 14, 2018
- SC 13G/ASCHEDULE 13G/AFeb 9, 2018
- SC 13G/ASep 11, 2017
- 15-12GSep 5, 2017
- EFFECTSep 1, 2017
- EFFECTSep 1, 2017
- 4/APRIMARY DOCUMENTAug 28, 2017
- POS AMAug 28, 2017
- POS AMAug 28, 2017
- AWAug 28, 2017
- AWAug 28, 2017
- 8-KAug 25, 2017
- 4PRIMARY DOCUMENTAug 24, 2017
- 4PRIMARY DOCUMENTAug 24, 2017
- 4PRIMARY DOCUMENTAug 24, 2017